Prediction Model for Chronic Intracranial Arterial Occlusion With Radiomic Features
NCT ID: NCT06066593
Last Updated: 2023-10-04
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
1000 participants
OBSERVATIONAL
2023-08-01
2024-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Our proposed project aims to address a significant scientific challenge: the precise assessment of long-term stroke risk in asymptomatic patients with chronic intracranial arterial occlusion using a machine learning-based approach. The rapidly advancing field of machine learning provides a rich set of solutions for tackling this problem. In this project, we intend to develop a deep learning-based segmentation model for key brain regions using multimodal CT scans. Subsequently, we will automate the extraction of radiomic features and CT perfusion parameters, followed by the application of machine learning techniques to construct a stroke risk prediction model tailored for patients with chronic intracranial arterial occlusion.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Risk Prediction Model for Cerebrovascular Events in Carotid Artery Stenosis
NCT06452173
Etiology and Prognostic Risk Factors of Intracerebral Hemorrhage in Beijing
NCT02350010
An Early Warning Model of Unfavorable Outcomes Following Endovascular Interventional Treatment of Intracranial Aneurysm
NCT06364293
Hemodynamic Analysis for Intracranial Aneurysms Recanalization After Endovascular Treatment
NCT02812108
Diagnosis by Comprehensive Cardiovascular Imaging for Stroke and TIA
NCT03618069
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The establishment of a brain segmentation model for key brain regions based on multimodal CT is one of the core components of this research. The project plans to use advanced algorithms such as U-Net and Transformer as the foundation to develop a model for automatically segmenting key brain regions in CT images. These key brain regions include the basal ganglia, frontal lobe, temporal lobe, parietal lobe, and others. The development of the automatic segmentation model consists of two main parts: training and validation. Retrospective cohort data from this research are used to constitute the training set. Specific brain regions are manually annotated to serve as training materials for the model. Parameter tuning and internal validation are conducted to achieve satisfactory training results. Prospective cohort data from this research form an independent validation set used for external validation of the model. The performance evaluation criteria for the model include the DICE coefficient and loss value.
2. Exploration of Core Neuroimaging Features Related to Stroke in Patients with Chronic Intracranial Arterial Occlusion
Using masks generated by the automatic segmentation model, this study intends to extract radiomic information and CT perfusion parameters of specific brain regions through a self-designed automated workflow. These features will be used to construct a machine learning predictive model for stroke risk in patients with chronic intracranial arterial occlusion. To select the most effective features for stroke prediction, a feature selection and dimensionality reduction process is required. This study plans to use L1 regularization to reduce the dimensionality of the standardized data, aiming to optimize the ROC area under the curve (AUC). Thus, it is possible to explore and refine core neuroimaging features related to stroke in patients with intracranial arterial occlusion, analyze their correlation with stroke, and use them for subsequent model construction.
3. Construction and Validation of a Stroke Prediction Model Based on Core Neuroimaging Features of Key Brain Regions
The construction and validation of the prediction model are divided into training and validation phases. The training data are collected from the training cohort and internally validated using cross-validation. The prospective cohort remains an independent validation set for external validation of the model. Model construction begins with testing basic machine learning models' performance. By analyzing the performance of these basic models, the architecture of an ensemble learning model is designed and constructed. Finally, the ensemble learning model is validated. The primary performance metric for the model is the area under the ROC curve (AUC), and additional evaluation metrics such as accuracy, recall, precision, and F1 score are used for supplementary assessment of performance.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Ischemic Stroke
MRI suggests a new cerebral infarction.
No interventions assigned to this group
Hemorrhagic Stroke
CT suggests a new cerebral hemorrhage.
No interventions assigned to this group
Asymptomatic Group
Without new infarction or hemorrhage
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Asymptomatic or with a history of only transient ischemic attacks (TIAs).
* The age of the patient falls within the range of 18 to 80 years old.
* Willing to undergo both perfusion CT scans and magnetic resonance imaging (MRI).
Exclusion Criteria
* History of either ischemic or hemorrhagic stroke.
* Allergies to contrast agents or conditions such as claustrophobia that prevent completion of imaging data acquisition.
18 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Beijing Tiantan Hospital
OTHER
Chinese Academy of Sciences
OTHER_GOV
Beijing Hospital
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Dong Zhang, Doctor
Role: STUDY_CHAIR
Beijing Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Beijing Tiantan Hospital
Beijing, Beijing Municipality, China
Beijing Hospital
Beijing, Beijing Municipality, China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2023BJYYEC-239-01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.